Anthony Vendetti
Stock Analyst at Maxim Group
(4.00)
# 499
Out of 4,847 analysts
79
Total ratings
29.58%
Success rate
24.27%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRMA Dermata Therapeutics | Maintains: Buy | $6 → $3 | $0.71 | +324.87% | 4 | May 21, 2025 | |
| NUTX Nutex Health | Maintains: Buy | $100 → $225 | $150.01 | +49.99% | 5 | May 20, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $14 → $10 | $4.82 | +107.47% | 6 | May 19, 2025 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $10 → $5 | $1.81 | +177.01% | 8 | May 8, 2025 | |
| AMIX Autonomix Medical | Initiates: Buy | $5 | $1.70 | +194.64% | 1 | Apr 29, 2025 | |
| BIAF bioAffinity Technologies | Downgrades: Hold | n/a | $0.29 | - | 2 | Apr 1, 2025 | |
| NXL Nexalin Technology | Upgrades: Buy | $5 | $1.23 | +308.16% | 3 | Mar 24, 2025 | |
| SSKN STRATA Skin Sciences | Initiates: Buy | $6 | $2.36 | +154.78% | 1 | Feb 27, 2025 | |
| BHST BioHarvest Sciences | Initiates: Buy | $12 | $6.58 | +82.37% | 1 | Dec 18, 2024 | |
| ACON Aclarion | Downgrades: Hold | n/a | $6.65 | - | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $1.05 | +661.90% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.78 | - | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $50 | $39.08 | +27.94% | 7 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.91 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $8.44 | +610.90% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.25 | +21.21% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.03 | +385.44% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.94 | +2,453.19% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.32 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $2.92 | -31.51% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $1.19 | +10,405.08% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.32 | +2,101.26% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $26.65 | -6.19% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.42 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $3,500 | $3.25 | +107,715.05% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $2.60 | +92.31% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.35 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.03 | +191.43% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.81 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8,000 | $5.01 | +159,580.64% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $45.67 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.86 | +84,100.68% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.23 | -51.12% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.50 | - | 1 | May 31, 2016 |
Dermata Therapeutics
May 21, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.71
Upside: +324.87%
Nutex Health
May 20, 2025
Maintains: Buy
Price Target: $100 → $225
Current: $150.01
Upside: +49.99%
Sensus Healthcare
May 19, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $4.82
Upside: +107.47%
The Hain Celestial Group
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.81
Upside: +177.01%
Autonomix Medical
Apr 29, 2025
Initiates: Buy
Price Target: $5
Current: $1.70
Upside: +194.64%
bioAffinity Technologies
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.29
Upside: -
Nexalin Technology
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $1.23
Upside: +308.16%
STRATA Skin Sciences
Feb 27, 2025
Initiates: Buy
Price Target: $6
Current: $2.36
Upside: +154.78%
BioHarvest Sciences
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $6.58
Upside: +82.37%
Aclarion
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $6.65
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $1.05
Upside: +661.90%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.78
Upside: -
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $39.08
Upside: +27.94%
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $7.91
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $60
Current: $8.44
Upside: +610.90%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $8.25
Upside: +21.21%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $1.03
Upside: +385.44%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.94
Upside: +2,453.19%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $10.32
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $2.92
Upside: -31.51%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $1.19
Upside: +10,405.08%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.32
Upside: +2,101.26%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $26.65
Upside: -6.19%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.42
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $6,000 → $3,500
Current: $3.25
Upside: +107,715.05%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $2.60
Upside: +92.31%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.35
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $1.03
Upside: +191.43%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $17.81
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $8,000
Current: $5.01
Upside: +159,580.64%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $45.67
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.86
Upside: +84,100.68%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.23
Upside: -51.12%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $0.50
Upside: -